Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Such roving imaging vans have been posed as a way to reach more women in rural and underserved communities. But do they unintentionally hurt facility-based efforts?
Between 2004 to 2021, the biggest annual percentage increase in incidence of metastatic breast cancer at diagnosis was among women ages 20-39 (up 2.9%).
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.
Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.
The FDA has OK’d two subsidiaries of Los Angeles-based RadNet to sell medical AI software—one product for diagnosing breast cancer, the other for streamlining MRI prostate reporting workflows.
Combining ensemble AI models with reads from breast radiologists of mixed experience levels can help health systems consistently diagnose malignant architectural distortion on mammography.
AB-MRI is a cost-effective means of screening women with dense breast tissue for breast cancer—as long as the per-exam costs don’t top 82% of what would have been spent to perform full-protocol breast MRI.
In addition to O-RADS external validation, experts also sought to determine if incorporating acoustic shadowing as a benign finding would improve diagnostic performance.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
